Cargando…

Prognostic Factors Associated with Ocriplasmin Efficacy for the Treatment of Symptomatic Vitreomacular Adhesion and Full-thickness Macular Hole: Analysis from Four Studies

PURPOSE: To assess the effect of patient baseline characteristics on the efficacy of ocriplasmin treatment for symptomatic vitreomacular adhesion (VMA) with full-thickness macular hole (FTMH) from phase 3/4 studies. METHODS: Patients with symptomatic VMA and FTMH at baseline and receiving ocriplasmi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Joondeph, Brian C., Willems, Paul, Raber, Thomas, Duchateau, Luc, Markoff, Joseph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PUBLISHED BY KNOWLEDGE E 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841271/ https://www.ncbi.nlm.nih.gov/pubmed/33520127 http://dx.doi.org/10.18502/jovr.v16i1.8250

Ejemplares similares

Visual function response to ocriplasmin for the treatment of vitreomacular traction and macular hole
por: Jackson, Timothy L., et al.
Publicado: (2017)

Cost-effectiveness of ocriplasmin for the treatment of vitreomacular traction and macular hole
por: Bennison, Craig, et al.
Publicado: (2016)

PATIENT-REPORTED VISUAL FUNCTION FROM THE OCRIPLASMIN FOR TREATMENT FOR SYMPTOMATIC VITREOMACULAR ADHESION, INCLUDING MACULAR HOLE (OASIS) STUDY
por: Mein, Calvin, et al.
Publicado: (2020)

Ocriplasmin for symptomatic vitreomacular adhesion: an evidence-based review of its potential
por: Song, Su Jeong, et al.
Publicado: (2014)

Early vitreomacular separation with delayed macular hole closure after ocriplasmin treatment
por: Liang, I-Chia, et al.
Publicado: (2016)

Effect of Funding Source on “Spin” in Studies of Ocriplasmin Therapy for Vitreomacular Traction and Macular Hole
por: Hubschman, Sasha, et al.
Publicado: (2020)

Profile of ocriplasmin and its potential in the treatment of vitreomacular adhesion
por: Stefanini, Francisco R, et al.
Publicado: (2014)

Predicting the individual probability of macular hole closure following intravitreal ocriplasmin injections for vitreomacular traction release using baseline characteristics
por: Bertelmann, Thomas, et al.
Publicado: (2021)

OCRIPLASMIN FOR VITREOMACULAR TRACTION IN CLINICAL PRACTICE: The INJECT Study
por: Steel, David H. W., et al.
Publicado: (2020)

Ocriplasmin for Treatment of Vitreomacular Traction: An Update
por: Khan, Mohammed Ali, et al.
Publicado: (2016)

Intravitreal ocriplasmin for the treatment of vitreomacular traction and macular hole- A study of efficacy and safety based on NICE guidance
por: Muqit, Mahiul M. K., et al.
Publicado: (2018)

ASSESSMENT OF ANATOMICAL AND FUNCTIONAL OUTCOMES WITH OCRIPLASMIN TREATMENT IN PATIENTS WITH VITREOMACULAR TRACTION WITH OR WITHOUT MACULAR HOLES: Results of OVIID-1 Trial
por: Tadayoni, Ramin, et al.
Publicado: (2019)

Incomplete Vitreomacular Traction Release Using Intravitreal Ocriplasmin
por: Chin, Eric K., et al.
Publicado: (2014)

Macular Hole Progression following Ocriplasmin Intravitreal Injection
por: Casswell, Edward, et al.
Publicado: (2014)

Myopic macular hole detachment associated with intravitreal ocriplasmin
por: Goh, Li Yen, et al.
Publicado: (2020)

Spontaneous Closure of a Full-Thickness Macular Hole Associated with Proliferative Diabetic Retinopathy and Persistent Vitreomacular Traction
por: Reinherz, Benjamin J., et al.
Publicado: (2016)

Calculating the individual probability of successful ocriplasmin treatment in eyes with vitreomacular traction–Validation and refinement of a multivariable prediction model
por: Paul, Christoph, et al.
Publicado: (2022)

Efficacy and Safety of Ocriplasmin Use for Vitreomacular Adhesion and Its Predictive Factors: A Systematic Review and Meta-Analysis
por: Chen, Xi, et al.
Publicado: (2022)

Transient visual loss and delayed resolution of vitreomacular traction after intravitreal ocriplasmin
por: DaCosta, Joanna, et al.
Publicado: (2014)

Functional improvement assessed by multifocal electroretinogram after Ocriplasmin treatment for vitreomacular traction
por: Rossi, Settimio, et al.
Publicado: (2016)

Vitreomacular traction quantitative cutoffs for the assessment of resolution after ocriplasmin intravitreal treatment
por: Arrigo, Alessandro, et al.
Publicado: (2020)

Recurrent Vitreomacular Traction in a Patient Treated with Ocriplasmin: A Case Report
por: Katsanos, Andreas, et al.
Publicado: (2020)

Redesigning services for the management of vitreomacular traction and macular hole
por: Amoaku, W, et al.
Publicado: (2014)

Apparent double macular hole caused by vitreomacular traction
por: Babu, Naresh, et al.
Publicado: (2020)

Cell composition at the vitreomacular interface in traumatic macular holes
por: Guenther, Stefanie R., et al.
Publicado: (2021)

Surgical Outcome of Vitreomacular Traction Associated With Macular Hole
por: Tayyab, Mashal, et al.
Publicado: (2022)

Partial-thickness macular hole in vitreomacular traction syndrome: a case report and review of the literature
por: Kumar, Niranjan, et al.
Publicado: (2010)

An Uncommon Aflibercept Side Effect: Full Thickness Macular Hole Formation After Intravitreal Injections in Patients With Pre-existing Vitreomacular Traction
por: Karamitsos, Athanasios, et al.
Publicado: (2021)

Spontaneous closure of idiopathic full-thickness macular hole after release of vitreomacular traction observed on spectral-domain optical coherence tomography
por: Canamary, Aristofanes, et al.
Publicado: (2022)

Comparison of Guided and Unguided Ocriplasmin Injection for the Treatment of Vitreomacular Traction: A Preliminary Study
por: Mastropasqua, Rodolfo, et al.
Publicado: (2016)

Visual functional changes after ocriplasmin injection for vitreomacular traction: A microperimetric analysis
por: Furino, Claudio, et al.
Publicado: (2020)

A Review of Current Management of Vitreomacular Traction and Macular Hole
por: García-Layana, Alfredo, et al.
Publicado: (2015)

An Assessment of Vitreous Degeneration in Eyes with Vitreomacular Traction and Macular Holes
por: Ghadiali, Quraish, et al.
Publicado: (2017)

Incidence and prevalence of vitreomacular traction with and without macular hole in Germany
por: Menzler, Jacob, et al.
Publicado: (2019)

Patient-reported outcomes of ocriplasmin for the treatment of vitreomacular traction: a systematic review and synthesis of the literature
por: Lescrauwaet, Benedicte, et al.
Publicado: (2019)

Effects of Vitreomacular Adhesion on Age-Related Macular Degeneration
por: Kang, Eui Chun, et al.
Publicado: (2015)

Post hoc analysis of ellipsoid zone changes beyond the central subfield in symptomatic vitreomacular adhesion patients from the OASIS trial
por: Velaga, Swetha Bindu, et al.
Publicado: (2021)

Ocriplasmin in the Treatment of Vitreomacular Traction in a Patient with Central Retinal Vein Occlusion: A Case Report
por: Rosati, Alessandra, et al.
Publicado: (2018)

Lamellar macular holes: evolving concepts and propensity for progression to full thickness macular hole
por: Asaad, Salim Zafar
Publicado: (2020)

Full-Thickness Macular Hole Progressing from Lamellar Macular Hole with Epiretinal Proliferation
por: Asaad, Salim Zafar
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l0vqkf5c3qeim7mjlsknajgf13